Business Description
BridgeBio Pharma is a drug development company focused on finding and delivering treatments for people living with genetic diseases. Founded in 2015 and based in Palo Alto, California, the company has several medicines either already on the market or in late-stage testing, targeting conditions that affect the heart, bones, muscles, and other areas driven by inherited genetic changes. BridgeBio works alongside partners such as Bayer, Alexion, Novartis, and Stanford University to advance its research and bring new therapies to patients.
